We are live on ! Find out more
AAMU

Amundi Asset Management US Portfolio holdings

AUM $131B
1-Year Est. Return 73.57%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+73.57%
3 Year Est. Return
+96.88%
5 Year Est. Return
+179.37%
10 Year Est. Return
AUM
$27.6B
AUM Growth
+$1.08B
Cap. Flow
-$1.1B
Cap. Flow %
-3.99%
Top 10 Hldgs %
16.67%
Holding
682
New
62
Increased
200
Reduced
266
Closed
71

Sector Composition

Rank Sector Weight
1 Healthcare 16.96%
2 Financials 14.96%
3 Technology 11.95%
4 Industrials 11.62%
5 Consumer Discretionary 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$5.02T
$759M 2.75%
27,511,540
+1,396,320
+5% +$38M
MSFT icon
2
Microsoft
MSFT
$2.91T
$757M 2.75%
16,286,645
+339,867
+2% +$16M
CVS icon
3
CVS Health
CVS
$138B
$529M 1.92%
5,496,034
+123,435
+2% +$10.9M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.05T
$429M 1.56%
16,288,899
+1,042,013
+7% +$28M
DIS icon
5
Walt Disney
DIS
$172B
$383M 1.39%
4,070,247
-242,189
-6% -$21.8M
CELG
6
DELISTED
Celgene Corp
CELG
$378M 1.37%
3,376,570
+296,196
+10% +$31.2M
EMC
7
DELISTED
EMC CORPORATION
EMC
$368M 1.33%
12,362,086
+519,254
+4% +$15.1M
ROST icon
8
Ross Stores
ROST
$80.3B
$349M 1.27%
7,411,976
-175,356
-2% -$7.4M
RTX icon
9
RTX Corp
RTX
$293B
$325M 1.18%
4,484,114
-344,647
-7% -$23.5M
WFC icon
10
Wells Fargo
WFC
$258B
$316M 1.15%
5,772,154
+1,212,883
+27% +$64.2M
GILD icon
11
Gilead Sciences
GILD
$166B
$300M 1.09%
3,180,990
-355,075
-10% -$36.7M
JNJ icon
12
Johnson & Johnson
JNJ
$644B
$285M 1.03%
2,722,369
-1,480,313
-35% -$156M
PNC icon
13
PNC Financial Services
PNC
$99.7B
$274M 0.99%
3,003,503
-456,387
-13% -$39.6M
AAL icon
14
American Airlines Group
AAL
$9.97B
$271M 0.98%
5,053,840
-688,061
-12% -$29.6M
BAC icon
15
Bank of America
BAC
$433B
$268M 0.97%
14,970,279
-20,313
-0.1% -$348K
HD icon
16
Home Depot
HD
$338B
$260M 0.94%
2,477,455
+88,784
+4% +$8.62M
MMM icon
17
3M
MMM
$93.3B
$250M 0.91%
1,820,060
-79,927
-4% -$10.3M
TMO icon
18
Thermo Fisher Scientific
TMO
$215B
$246M 0.89%
1,965,136
-20,395
-1% -$2.48M
HSY icon
19
Hershey
HSY
$37.8B
$246M 0.89%
2,368,523
-119,930
-5% -$11.7M
LO
20
DELISTED
LORILLARD INC COM STK
LO
$235M 0.85%
3,729,183
+155,941
+4% +$9.65M
ESRX
21
DELISTED
Express Scripts Holding Company
ESRX
$226M 0.82%
2,667,725
-37,082
-1% -$2.9M
AET
22
DELISTED
Aetna Inc
AET
$219M 0.79%
2,463,870
+2,520
+0.1% +$211K
CAH icon
23
Cardinal Health
CAH
$54.4B
$213M 0.77%
2,639,786
+203,338
+8% +$16.1M
MS icon
24
Morgan Stanley
MS
$323B
$206M 0.75%
5,316,312
-309,825
-6% -$11M
COV
25
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$205M 0.75%
2,008,046
+237,153
+13% +$22.7M

Similar funds

Amundi Asset Management US's Q4 2014 Portfolio in Review

As of Q4 2014, Amundi Asset Management US held 682 positions worth $27.6B, up 4.1% from $26.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Amundi Asset Management US withdrew a net $1.1B in Q4 2014, closing 71 positions and reducing 266 holdings. Its most notable exit was KODIAK OIL & GAS CORP, an estimated $92.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Amundi Asset Management US opened a new position in Exelon worth $47M.

  • Amundi Asset Management US's largest Q4 2014 buy was Exelon: 1,776,138 shares worth $47M.
  • Amundi Asset Management US added most to ExxonMobil in Q4 2014, an estimated $140M increase.
  • Amundi Asset Management US's biggest Q4 2014 reduction was Johnson & Johnson, cutting an estimated $156M.
  • Amundi Asset Management US fully exited KODIAK OIL & GAS CORP in Q4 2014, selling an estimated $92.4M.
  • Amundi Asset Management US's ten largest holdings make up 17% of its $27.6B portfolio in Q4 2014.
  • Amundi Asset Management US opened 62 new positions and closed 71 in Q4 2014.
  • Amundi Asset Management US's portfolio value rose 4.1% quarter-over-quarter to $27.6B.

Based on Amundi Asset Management US's 13F filing for Q4 2014, filed 9 Feb 2015.